Endocrinology, Vol 127, 1278-1286, Copyright © 1990 by Endocrine Society

ARTICLES

Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy

ML Davenport, DR Clemmons, MV Miles, C Camacho-Hubner, AJ D'Ercole and LE Underwood
Department of Pediatrics, Schools of Medicine, University of North Carolina, Chapel Hill 27599.

Serum concentrations of insulin-like growth factor-I (IGF-I) in rats are reduced dramatically in the latter half of pregnancy, decreasing from 1758 +/- 356 ng/ml at 12 days of pregnancy (mean +/- SD) to 761 +/- 192 ng/ml at 15 days. After parturition, IGF-I increases to nonpregnant values in 4 days. Using ligand blotting, we have demonstrated that most of the serum IGF binding proteins (IGFBPs) are concurrently reduced during pregnancy. IGFBP-3, the predominant IGFBP in nonpregnant serum, is reduced to 1.3% of nonpregnant values by 21 days of pregnancy and begins to rise within 1 h postpartum (PP). The sera of 21-day pregnant (but not nonpregnant) rats degrade IGFBP-3 in vitro, and this degradation is prevented by the protease inhibitor antipain. Decreased serum IGF-I concentrations during pregnancy, therefore, may result from reduced IGFBP-3 concentrations causing increased IGF-I clearance. In addition, steady state IGF-I mRNA and peptide levels in liver are decreased in 21-day pregnant rats (37% and 42% of 4 day PP levels, respectively), suggesting that decreased synthesis of IGF-I may also lead to lower serum IGF-I concentrations. After bolus injection, [125I]IGF-I is cleared from the serum of pregnant rats nearly 5 times faster than that of 4 day PP rats (1.21 vs. 0.25 ml/min/kg, respectively). Urinary clearance is relatively insignificant (less than 4%), and [125I]IGF-I does not cross the placenta. The intermediate distribution phase of IGF-I is slower in pregnant rats than in PP rats (t1/2 alpha, 17.1 vs. 5.4 min), whereas the terminal elimination of IGF- I is twice as fast (t1/2 beta, 228.1 vs. 106.4 min). The prolonged IGF- I distribution phase in the pregnant rats may result from decreased concentrations of 34,000 and 30,000 mol wt IGFBPs, which may transport IGF-I to tissues. The faster serum elimination half-life may result from diminished IGFBP-3, leading to greater IGF-I availability to tissues in pregnancy.

This article has been cited by other articles:

				J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E600 - E607. [Abstract] [Full Text] [PDF]

				F. Miraki-Moud, A. B. Grossman, M. Besser, J. P. Monson, and C. Camacho-Hubner A Rapid Method for Analyzing Serum Pro-Insulin-Like Growth Factor-II in Patients with Non-Islet Cell Tumor Hypoglycemia J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3819 - 3823. [Abstract] [Full Text] [PDF]

				D. R. Clemmons Use of Mutagenesis to Probe IGF-Binding Protein Structure/Function Relationships Endocr. Rev., December 1, 2001; 22(6): 800 - 817. [Abstract] [Full Text] [PDF]

				F. De Benedetti, C. Meazza, M. Oliveri, P. Pignatti, M. Vivarelli, T. Alonzi, E. Fattori, S. Garrone, A. Barreca, and A. Martini Effect of IL-6 on IGF Binding Protein-3: A Study in IL-6 Transgenic Mice and in Patients with Systemic Juvenile Idiopathic Arthritis Endocrinology, November 1, 2001; 142(11): 4818 - 4826. [Abstract] [Full Text] [PDF]

				M. Binoux Tools Now Exist to Measure Circulating IGF-Binding Protein-3 Proteolysis, to Study Its Regulation and Its Effects on IGF-I Bioavailability J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5088 - 5089. [Full Text] [PDF]

				A. Diamandi, J. Mistry, R. G. Krishna, and J. Khosravi Immunoassay of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3): New Means to Quantifying IGFBP-3 Proteolysis J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2327 - 2333. [Abstract] [Full Text]

				J. C. Irwin, L.-F. Suen, B.-H. Cheng, R. Martin, P. Cannon, C. L. Deal, and L. C. Giudice Human Placental Trophoblasts Secrete a Disintegrin Metalloproteinase Very Similar to the Insulin-Like Growth Factor Binding Protein-3 Protease in Human Pregnancy Serum Endocrinology, February 1, 2000; 141(2): 666 - 674. [Abstract] [Full Text] [PDF]

				R.P. Holmes, J.M.P. Holly, and P.W. Soothill Maternal serum insulin-like growth factor binding protein-2 and -3 and fetal growth Hum. Reprod., July 1, 1999; 14(7): 1879 - 1884. [Abstract] [Full Text] [PDF]

				J. G. Robertson, D. A. Belford, and F. J. Ballard Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E663 - E671. [Abstract] [Full Text] [PDF]

				M. T. Spicer, B. J. Stoecker, T. Chen, and L. J. Spicer Maternal and Fetal Insulin-Like Growth Factor System and Embryonic Survival During Pregnancy in Rats: Interaction between Dietary Chromium and Diabetes J. Nutr., December 1, 1998; 128(12): 2341 - 2347. [Abstract] [Full Text]

				A. Nishimura, M. Fujimoto, S. Oguchi, R. D. Fusunyan, R. P. MacDermott, and I. R. Sanderson Short-chain fatty acids regulate IGF-binding protein secretion by intestinal epithelial cells Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E55 - E63. [Abstract] [Full Text] [PDF]

				B. Kubler, S. Cowell, J. Zapf, and T. Braulke Proteolysis of Insulin-Like Growth Factor Binding Proteins by a Novel 50-Kilodalton Metalloproteinase in Human Pregnancy Serum Endocrinology, April 1, 1998; 139(4): 1556 - 1563. [Abstract] [Full Text] [PDF]

				K. Chan and E. M. Spencer Megakaryocytes Endocytose Insulin-Like Growth Factor (IGF) I and IGF-Binding Protein-3: A Novel Mechanism Directing Them into {alpha} Granules of Platelets Endocrinology, February 1, 1998; 139(2): 559 - 565. [Abstract] [Full Text] [PDF]

				W. J. Smith, L. E. Underwood, L. Keyes, and D. R. Clemmons Use of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein Measurements to Monitor Feeding of Premature Infants J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3982 - 3988. [Abstract] [Full Text] [PDF]

				J. Escalada, F. Sanchez-Franco, B. Velasco, and L. Cacicedo Regulation of Growth Hormone (GH) Gene Expression and Secretion During Pregnancy and Lactation in the Rat: Role of Insulin-Like Growth Factor-I, Somatostatin, and GH-Releasing Hormone Endocrinology, August 1, 1997; 138(8): 3435 - 3443. [Abstract] [Full Text] [PDF]